Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET)

AIM: To investigate the budget implications of treatment with glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) versus other glucose‐lowering treatment (here termed ‘standard of care’ [SoC]) during 2012‐2019. MATERIALS AND METHODS: GLP‐1 RA‐naïve adults with type 2 diabetes (T2D) in the IBM Mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Marc, Chandramouli, Abhishek Shankar, Faurby, Mads, Matthiessen, Kasper Sommer, Mogensen, Phillip Bredahl, Verma, Subodh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324926/
https://www.ncbi.nlm.nih.gov/pubmed/35504854
http://dx.doi.org/10.1111/dom.14703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324926/
https://www.ncbi.nlm.nih.gov/pubmed/35504854
http://dx.doi.org/10.1111/dom.14703

Ejemplares similares